Clinical Trial Update: Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

Completed clinical trial evaluating Electrical Vestibular Nerve Stimulation (VeNS) versus sham for glycemic control in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• VeNS (Electrical Vestibular Nerve Stimulation)

Snippet

Sponsor: Neurovalens Ltd. | Conditions: Type 2 Diabetes | NA | Status: COMPLETED